XANTHINE OXIDOREDUCTASE: ACTIVITY OF BLOOD IN RHEUMATOID ARTHRITIS

Keywords: rheumatoid arthritis, plasma, red blood cells, xanthine oxidoreductase, xanthine oxidase, xanthine dehydrogenase

Abstract

Metabolic shifts are essential for pathogenesis of rheumatoid arthritis (RA) along with changes in immunity.

Objective. Overviewing of xanthine oxidoreductase (XOR) activity pattern in plasma and lyzed red blood cells of RA patients.

Methods. 77 RA patients as well as 35 normal control persons were included in the study. Ethical principles of the World Medical Association Declaration of Helsinki were fully compliant during the research. We verified RA diagnosis using ACR/EULAR criteria (2010). Erythrocytes were separated from whole blood by means of density gradients and lyzed by triple freezing and thawing cycles followed by centrifugation. Xanthine oxidase (XO) and xanthine dehydrogenase (XDH) activities of XOR were quantitated by spectrophotometry. Statistic calculations were performed with STATISTICA 6 software.

Results. Both plasma and lyzed red blood cells had changes in XO as well as XDH activities related to clinical manifestations of RA. Gradual decrease of XDH activity along with disease flares were revealed in both investigated compartments. Extraarticular involvement was associated with increase of both enzymatic activities in plasma, increase of erythrocyte XO, and decrease of erythrocyte XDH. Highest oxidase activities were observed in X-ray stages II and III. High global functional classes of RA were characterized by high XO activities in plasma and RBCs as well as low XDH activities in RBCs.

Conclusion. Increased production of reactive oxygen and nitrogen species is considered to be a major pathogenetic implication of XOR activity. Enhancement of free radical oxidation supports chronic inflammation and destruction in joints, as well as in other organs and systems.

Downloads

Download data is not yet available.

Author Biographies

Elena E. Mozgovaya, Research Institute of Clinical and Experimental Rheumatology named after A.B. Zborovsky

Cand.Med.Sci., Lead Researcher of the Laboratory of Clinical Biochemistry

Svetlana A. Bedina, Research Institute of Clinical and Experimental Rheumatology named after A.B. Zborovsky

Cand.Med.Sci., Senior Researcher of the Laboratory of Clinical Biochemistry

Maria A. Mamus, Research Institute of Clinical and Experimental Rheumatology named after A.B. Zborovsky

Junior Researcher of the Laboratory of Clinical Bioche­mistry

Andrew S. Trofimenko, Research Institute of Clinical and Experimental Rheumatology named after A.B. Zborovsky

Cand.Med.Sci., Managing Researcher of the Laboratory of Clinical Biochemistry

Svetlana S. Spitsina, Research Institute of Clinical and Experimental Rheumatology named after A.B. Zborovsky

Junior Researcher of the Laboratory of Clinical Biochemistry

References

Bedina S.A., Trofimenko A.S., Mozgovaya E.E., Spitsina S.S., Mamus M.A., Tikhomirova E.A. Yakutskiy meditsinskiy zhurnal, 2020, no. 2, pp. 28-30. https://doi.org/10.25789/YMJ.2020.70.08

Bestaev D.V., Karateev D.E., Nasonov E.L. Nauchno-prakticheskaya revmatologiya, 2013, vol. 51, no. 1, pp. 76-80. https://rsp.mediar-press.net/rsp/article/view/1116

Galushko E.A., Nasonov E.L. Al’manakh klinicheskoy meditsiny, 2018, vol. 46, no. 1, pp. 32–39. https://doi.org/10.18786/2072-0505-2018-46-1-32-39

Zinchuk I.Yu., Amirdzhanova V.N. Nauchno-prakticheskaya revmatologiya, 2014, no. 3, pp. 331–335. https://doi.org/10.47360/1995-4484-2020-663-672

Satybaldyev A.M., Demidova N.V., Gridneva G.I., Nikishina N.Yu., Gerasimova E.V., Gukasyan D.A., Kasumova K.A., Luchikhina E.L., Mi-siyuk A.S., Oskilko T.G., Rumyantseva O.A., Zlepko E.A., Tyurina L.N., Fedorenko E.V., Shornikova N.V., Nasonov E.L. Nauchno-prakticheskaya revmatologiya, 2020, vol. 58, no. 2, pp. 140-146. https://rsp.mediar-press.net/rsp/article/view/2868

Karpishchenko A.I. Meditsinskie laboratornye tekhnologii: Rukovodstvo po klinicheskoy laboratornoy diagnostike [Medical laboratory technology: Guidelines for clinical laboratory diagnosis]. М.: GEOTAR-Media, 2013, vol. 2, 792 p.

Korolev M.A., Ubshaeva Yu.B., Banshchikova N.E., Letyagina E.A., Mullagaliev A.A. Nauchno-prakticheskaya revmatologiya, 2020, vol. 58, no. 6, pp. 663–672. https://doi.org/10.47360/1995-4484-2020-663-672

Rybakova A.A., Platonova N.M., Troshina E.A. Problemy endokrinologii, 2019, vol. 65, no. 6, pp. 451-457. https://doi.org/10.14341/probl11827

Sheybak V.M., Pavlyukovets A.Yu., Smirnov V.Yu. Problemy zdorov’ya i ekologii, 2017, no. 2, pp. 67-71. https://journal.gsmu.by/jour/article/view/1793

Mozgovaya E.E., Martem’yanov V.F., Stazharov M.Yu., Bedina S.A. Vrach-aspirant, 2011, no. 4, pp. 45-50.

Aletaha D., Neogri T., Silman A.J. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatology, 2010, vol. 62, no. 9, pp. 2569-2581. https://doi.org/10.1002/art.27584

Battelli M.G., Bolognesi A., Polito L. Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, vol. 1842, issue 9, pp. 1502-1517. https://doi.org/10.1016/j.bbadis.2014.05.022

Battelli M.G., Bortolotti M., Polito L., Bolognesi A. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase. Redox Biology, 2019 Feb, vol. 21, 101070. https://doi.org/10.1016/j.redox.2018.101070

Battelli M.G., Polito L., Bortolotti M., Bolognesi A. Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects. Oxidative Medicine and Cellular Longevity, 2016, vol. 2016, 3527579. https://doi.org/10.1155/2016/3527579

Çimen M.Y., Çimen Ö.B., Kaçmaz M., Öztürk H.S., Yorgancioğlu R., Durak İ. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clinical Rheumatology, 2000, vol. 19, no. 4, pp. 275-277. https://doi.org/10.1007/s00296-010-1611-2

Fearon, U., Canavan, M., Biniecka, M. et al. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nature Reviews Rheumatology, 2016, vol. 12, pp. 385–397. https://doi.org/10.1038/nrrheum.2016.69

da Fonseca L.J.S., Nunes-Souza V., Goulart M.O.F., Rabelo L.A. Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies. Oxidative Medicine and Cellular Longevity, 2019 Dec, vol. 14, 7536805. https://doi.org/10.1155/2019/7536805

Mateen S., Moin S., Khan A.Q., Zafar A., Fatima N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. PLOS ONE, 2016, vol. 11, no. 4, e0152925. https://doi.org/10.1371/journal.pone.0152925

McInnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet, 2017, vol. 389, issue 10086, pp. 2328–2337. https://doi.org/10.1016/S0140-6736(17)31472-1

Smallwood M.J., Nissim A., Knight A.R., Whiteman M., Haigh R., Winyard P.G. Oxidative stress in autoimmune rheumatic diseases. Free Radical Biology & Medicine, 2018 Sep, vol. 125, pp. 3-14. https://doi.org/10.1016/j.freeradbiomed.2018.05.086

Staron A., Makosa G., Koter-Michalak M. Oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatology International, 2012, vol. 32, pp. 331-334. https://doi.org/10.1007/s00296-010-1611-2

Abstract views: 294

Published
2021-06-30
How to Cite
Mozgovaya, E., Bedina, S., Mamus, M., Trofimenko, A., & Spitsina, S. (2021). XANTHINE OXIDOREDUCTASE: ACTIVITY OF BLOOD IN RHEUMATOID ARTHRITIS. Siberian Journal of Life Sciences and Agriculture, 13(3), 288-304. https://doi.org/10.12731/2658-6649-2021-13-3-288-304
Section
Biomedical Chemistry